Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
209,790.00 Euro
Forbid offers above base price:
Request Reference:
45040423
Request Name:
Aquisição do Medicamento EMTRICITABINA + TENOFOVIR [200+245 MG; CÁP/COMP] II ao abrigo do CPA 2023/481
Phase:
Tendering Phase
State:
Awarded
Description:
Aquisição do Medicamento EMTRICITABINA + TENOFOVIR [200+245 MG; CÁP/COMP] II ao abrigo do CPA 2023/481
Procedure Type:
VortalGOV - Acquisition under a Framework Agreement (via Direct Award)
Lot Name
Lot Base Price
Expected Duration
E220 - EMTRICITABINA + TENOFOVIR [200+245 MG; CÁP/COMP]
209,790.00 Euro
2
(
Months
)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Alameda Prof Hernâni Monteiro Paranhos Porto Área Metropolitana do Porto PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
10/27/2023 9:49 AM
(UTC +1 hour)
National official publishing date and time (DR):
5/29/2023 12:00 AM
(UTC +1 hour)
Due datetime for receiving replies:
10/30/2023 5:00 PM
(UTC 0 hours)
Financial Settings
Financial Settings
Define Advance Payments?
No
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
Convite_AQ_CPA20230481_CHUSJ.pdf
Convite_AQ_CPA20230481_CHUSJ.pdf
Download
Anexo_I_Mapa_QT_QA_CPA 20230481.xlsx
Anexo_I_Mapa_QT_QA_CPA 20230481.xlsx
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
1
Questionário
1.1
Lote 1
Section for Lot - E220 - EMTRICITABINA + TENOFOVIR [200+245 MG; CÁP/COMP]
1.1.1
Lote 1
Bill of Quantities
*
(Os valores indicados não incluem o IVA)
Solicitou requisitos adicionais nesta lista de preços.
Preço Total
Total without VAT
0,00
EUR
Cód. Artigo
Referência Interna
Descrição
Qt
Unidade
Preço Unitário
Preço Total
Reference
E220
Internal Reference
Description
EMTRICITABINA + TENOFOVIR [200+245 MG; CÁP/COMP]
Qty
49.950,000000
Unit
UN
Price per Unit
Total
Comentários do Comprador:
502248793 | Mylan, Lda. | CPA:2023481/120/0091 | NºAIM:5703269; 503604704 | Gilead Sciences, Lda. | CPA:2023481/229/0057 | NºAIM:5253281; 507045491 | Teva Pharma - Produtos Farmacêuticos, Lda. | CPA:2023481/334/0019 | NºAIM:5680160; 507981227 | Krka Farmacêutica, Lda. | CPA:2023481/901/0231 | NºAIM:5705124;
Evaluation
Evaluation
Evaluation General Settings
Evaluation General Settings
Evaluation guideline
MostEconomicallyAdvantageousTender
Evaluation Method
Manual
Evaluation Items
Evaluation Items
Name
Lot
Regras de avaliação para o lote 1
1 - E220 - EMTRICITABINA + TENOFOVIR [200+245 MG; CÁP/COMP]
Critérios de Adjudicação
Peso (%)**
1
Preço
100
Define tie breaking rules?
Yes
No
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...